Journal List > J Rheum Dis > v.21(4) > 1064115

Suh: Vitamin D and Cardiovascular Risk in Patients with Rheumatoid Arthritis

REFERENCES

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81.
crossref
2. Dessein PH. Vitamin D replacement therapy: a promising adjunct in cardiovascular risk management among patients with rheumatoid arthritis? J Rheumatol. 2013; 40:1463–5.
crossref
3. McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med. 2011; 155:820–6.
4. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010; 152:315–23.
crossref
5. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a metaanalysis of observational studies. Ann Rheum Dis. 2012; 71:1524–9.
crossref
6. Baker JF, Mehta NN, Baker DG, Toedter G, Shults J, Von Feldt JM, et al. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am J Med. 2012; 125:1036.e9-1036.e15.
crossref
7. Haque UJ, Bathon JM, Giles JT. Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012; 64:1497–504.
crossref
8. Goshayeshi L, Saber H, Sahebari M, Rezaieyazdi Z, Rafatpanah H, Esmaily H, et al. Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis. Clin Rheumatol. 2012; 31:1197–203.
crossref
9. Ranganathan P, Khalatbari S, Yalavarthi S, Marder W, Brook R, Kaplan MJ. Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis. J Rheumatol. 2013; 40:1529–34.
crossref
10. Park JM, Lee SG, Park EK, Lee DS, Baek SM, Hwang KL, et al. Association between Vitamin D Deficiency and Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis. J Rheum Dis. 2014; 21:132–9.
crossref

Table 1.
Vitamin D and cardiovascular risk factors in rheumatoid arthritis
Authors No. Age (years) Study site 25(OH) D level (ng/mL) Vitamin D def. (%)* Essential findings
Baker et al. 499 49.5±12.4 Global 20.7 (14.5∼28.2) 48 25(OH) D is associated inversely with LDL-cholesterol and triglyceride
            Vitamin D deficiency is associated with an increased odds of hyperlipidemia and metabolic syndrome
Haque et al. 179 61.0±8.0 Baltimore, USA 34.0±10.0 73 (<30 ng/mL) 25(OH) D is associated with HDL-cholesterol and inversely associated with E-selectin and sICAM-1
Goshayeshi et al. 120 45.5±14.2 Iran 27.1±13.6 46 25(OH) D is associated negatively with BMI
          72 (<30 ng/mL) 25(OH) D is a protective factor against metabolic syndrome
Ranganathan et al. 87 55.2±12.1 Missouri & Michigan, USA 27.1±13.6 25 25(OH) D is inversely associated with IL-17
          59 (<30 ng/mL) In vitamin D-deficient patients, 25(OH) D is positively associated with microvascular function
Park et al. 50 56.0±11.2 Busan, Korea 14.0 (11.0∼20.7) 37 Vitamin D deficiency is associated with increased CIMT in female patients

25(OH) D: 25 hydroxyvitamin D, LDL: low-density lipoprotein, HDL: highdensity lipoprotein, ICAM: intercellular adhesion molecule, BMI: body mass index, IL: interleukin, CIMT: carotid intima-media thickness.

* Vitamin D deficiency; 25(OH)D <20 ng/mL.

Interquartile range.

TOOLS
Similar articles